
Divaglipt M 500mg/20mg Tablet ER
Marketer
Diva Health Care
Salt Composition
Metformin (500mg) + Teneligliptin (20mg)
Overview Divaglipt M 500mg/20mg Tablet ER
Metformin/Vildagliptin extended-release tablets (500mg/20mg) manage elevated blood glucose in type 2 diabetes patients. This dual-action medication mitigates severe diabetic complications like nephropathy and retinopathy, potentially lessening cardiovascular event risk. It may be prescribed as monotherapy or adjunctive therapy with other antidiabetic agents. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is individualized, considering your health status, glycemic control, and concurrent medications. Ingestion with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Effective blood sugar regulation prevents future complications. Continued adherence to your prescribed diet and exercise plan is crucial. Lifestyle modifications significantly influence diabetes management. Common side effects include nausea, vomiting, diarrhea, abdominal discomfort, and headache. Hypoglycemia is a potential risk, especially when combined with insulin or sulfonylureas; learn to recognize and treat it. This medication is not universally suitable. Prior to initiating treatment, inform your doctor of any history of kidney, liver, or heart disease, pancreatic disorders, or excessive alcohol consumption. Pregnant or lactating individuals should seek medical counsel before use. Potential drug interactions necessitate comprehensive disclosure of all medications to your physician for safety assurance. Alcohol consumption should be minimized due to its hypoglycemic effects. Your doctor will monitor kidney function and blood glucose levels throughout treatment.
Uses of Divaglipt M 500mg/20mg Tablet ER
Managing type 2 diabetes
Major Benefits of Divaglipt M 500mg/20mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or breaking it. The Divaglipt M 500mg/20mg Extended-Release Tablet should be administered with a meal.
Common Side effects of Divaglipt M 500mg/20mg Tablet ER:
- Nausea
- Vomiting
- Headache
- Hypoglycemia (low blood glucose level)
- Diarrhea
How to use Divaglipt M 500mg/20mg Tablet ER:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the entire tablet without chewing, crushing, or fracturing it. The Divaglipt M 500mg/20mg Extended-Release tablet should be administered with a meal.
How Divaglipt M 500mg/20mg Tablet ER works:
Extended-release Divaglipt M tablets (500mg/20mg) contain a dual-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Divaglipt M 500mg/20mg Extended-Release Tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Divaglipt M 500mg/20mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Divaglipt M 500mg/20mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Divaglipt M 500mg/20mg Tablet ER on driving ability is undetermined. Refrain from driving if symptoms impairing concentration or reaction time occur.
KidneyCAUTION
Patients with kidney impairment should use Divaglipt M 500mg/20mg Extended-Release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Divaglipt M 500mg/20mg Extended-Release tablets. Physician consultation is recommended. Regular kidney function assessments are advised during treatment.
LiverUNSAFE
Extended-release Divaglipt M 500mg/20mg tablets are likely contraindicated for individuals with hepatic impairment and should be omitted. Medical advice is recommended.
What if you forget to take Divaglipt M 500mg/20mg Tablet ER :
Should you forget a Divaglipt M 500mg/20mg Extended-Release Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Divaglipt M 500mg/20mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
